Stock Fundamentals

Company Information

▼
Company Name
Werewolf Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US95075A1079
CIK: 0001785530
CUSIP: 95075A107
Currency: USD
Full Time Employees: 39
Phone: 617 952 0555
Website: https://werewolftx.com
Fiscal Year End: December
IPO Date: Apr 30, 2021
Description:

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Address:

200 Talcott Ave, Watertown, MA, United States, 02472

Directors & Officers

▼
Name Title Year Born
Dr. Daniel J. Hicklin Ph.D. Founder, CEO, President, Secretary & Director 1964
Mr. Michael Urban VP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer 1981
Mr. Steven H. Bloom R.Ph. Chief Business Officer 1961

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 6.68M Dec 31, 2025 13.76% $0.04 0.00%
Mpm Asset Management, LLC 4.31M Sep 30, 2025 8.88% $19.08 0.00%
MPM Oncology Impact Management LP 2.41M Sep 30, 2025 4.96% $0.78 0.00%
Bank of America Corp 1.83M Sep 30, 2025 3.77% $0.00 -14.03%
Vanguard Group Inc 1.41M Dec 31, 2025 2.90% $0.00 0.00%
Renaissance Technologies Corp 677.77K Dec 31, 2025 1.40% $0.00 48.63%
Sphera Funds Management Ltd. 626.81K Dec 31, 2025 1.29% $0.08 0.00%
DC Funds, LP 589.10K Sep 30, 2025 1.21% $37.32 0.00%
Partner Fund Management LP 401.11K Sep 30, 2025 0.83% $0.06 0.00%
Geode Capital Management, LLC 330.79K Sep 30, 2025 0.68% $0.00 0.86%
Millennium Management LLC 317.05K Sep 30, 2025 0.65% $0.00 -54.49%
Jane Street Group LLC 268.58K Sep 30, 2025 0.55% $0.00 -28.37%
Alyeska Investment Group, L.P. 235.71K Dec 31, 2025 0.49% $0.00 0.00%
Citadel Advisors Llc 154.53K Sep 30, 2025 0.32% $0.00 0.00%
State Street Corp 119.17K Sep 30, 2025 0.25% $0.00 0.00%
BlackRock Inc 101.32K Sep 30, 2025 0.21% $0.00 -72.01%
Susquehanna International Group, LLP 93.04K Sep 30, 2025 0.19% $0.00 16.88%
Bridgeway Capital Management, LLC 77.00K Dec 31, 2025 0.16% $0.00 -24.51%
Northern Trust Corp 65.84K Sep 30, 2025 0.14% $0.00 0.00%
The Goldman Sachs Group Inc 60.34K Sep 30, 2025 0.12% $0.00 -73.47%

Shares Statistics

▼
Shares Outstanding: 48.54M
Shares Float: 41.18M
% Insiders: 561.10%
% Institutions: 4,114.50%
Short % Float: 5.79%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 RA Capital Management, LLC 6.68M 13.76% ▲ 0.00% Dec 31, 2025
2 Mpm Asset Management, LLC 4.31M 8.88% ▲ 0.00% Sep 30, 2025
3 MPM Oncology Impact Management LP 2.41M 4.96% ▲ 0.00% Sep 30, 2025
4 Bank of America Corp 1.83M 3.77% ▼ 14.03% Sep 30, 2025
5 Vanguard Group Inc 1.41M 2.90% ▲ 0.00% Dec 31, 2025
6 Renaissance Technologies Corp 677.77K 1.40% ▲ 48.63% Dec 31, 2025
7 Sphera Funds Management Ltd. 626.81K 1.29% ▲ 0.00% Dec 31, 2025
8 DC Funds, LP 589.10K 1.21% ▲ 0.00% Sep 30, 2025
9 Partner Fund Management LP 401.11K 0.83% ▲ 0.00% Sep 30, 2025
10 Geode Capital Management, LLC 330.79K 0.68% ▲ 0.86% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $868.45K
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $29.13M
EBITDA: $-69.93M
Book Value: $0.63
Earnings/Share: $-1.62
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -40.75%
ROE (TTM): -122.43%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 7.45x 0.38x 0.42x -15.81x -0.43x
2023-12-31 7.14x 0.37x 0.36x -12.90x -1.26x
2022-12-31 5.84x 0.02x 0.24x -50.78x -0.04x
2021-12-31 13.56x 0.01x 0.15x -231.88x -0.02x
2020-12-31 17.58x 0.01x 0.07x -221.82x -0.05x
2019-12-31 8.84x 0.06x 0.55x -26.71x -0.06x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 16, 2026 Luke Evnin N/A Sale 38.78K $0.54 $20.94K
Jan 15, 2026 Luke Evnin N/A Sale 37.41K $0.55 $20.58K
Jan 14, 2026 Luke Evnin N/A Sale 30.62K $0.57 $17.45K
Jan 13, 2026 Luke Evnin N/A Sale 43.20K $0.55 $23.76K
Jan 12, 2026 Luke Evnin N/A Sale 58.98K $0.57 $33.62K
Jan 09, 2026 Luke Evnin N/A Sale 24.68K $0.61 $15.05K
Jan 08, 2026 Luke Evnin N/A Sale 7.72K $0.63 $4.86K
Jan 07, 2026 Luke Evnin N/A Sale 11.92K $0.64 $7.63K
Jan 06, 2026 Luke Evnin N/A Sale 40.76K $0.65 $26.49K
Jan 05, 2026 Luke Evnin N/A Sale 18.38K $0.64 $11.76K
Jan 02, 2026 Luke Evnin N/A Sale 18.57K $0.63 $11.70K
Dec 31, 2025 Luke Evnin N/A Sale 24.96K $0.62 $15.48K
Dec 30, 2025 Luke Evnin N/A Sale 34.85K $0.61 $21.26K
Dec 29, 2025 Luke Evnin N/A Sale 108.61K $0.61 $66.25K
Dec 26, 2025 Luke Evnin N/A Sale 35.63K $0.63 $22.45K
Dec 24, 2025 Luke Evnin N/A Sale 16.31K $0.65 $10.60K
Dec 23, 2025 Luke Evnin N/A Sale 71.43K $0.63 $45.00K
Dec 22, 2025 Luke Evnin N/A Sale 59.31K $0.69 $40.92K
Dec 17, 2025 Luke Evnin N/A Sale 9.98K $1.14 $11.38K
Dec 16, 2025 Luke Evnin N/A Sale 14.55K $1.05 $15.28K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HOWL.US!